- 1College of Pharmacy, Sunchon National University, Sunchon, South Korea
- 2College of Pharmacy, Sookmyung Women’s University, Seoul, South Korea
- 3Faculty of Arts and Sciences, Department of Biology, Marmara University, Istanbul, Turkey
- 4Korean Lichen Research Institute, Sunchon National University, Sunchon, South Korea
Background: Endolichenic fungi (ELF), which live the inside the lichen thallus, contain many secondary metabolites that show various biological activities. Recent studies show that lichen and ELF secondary metabolites have antioxidant, antibacterial, antifungal, cytotoxic, and anticancer activities.
Purpose: Here, the effects of an ELF extract and its bioactive compounds were investigated on the H1975 cell line focusing on immune checkpoint marker inhibition.
Methods: An ELF was isolated from the host lichen Bryoria fuscescens (Gyelnik) Brodo and D. Hawksw and identified the species as Nemania sp. EL006872. The fungus was cultured on agar medium and acetonic extracts were obtained. Secondary metabolites radianspenes C and D, and dahliane D, were isolated from the crude extract. The biological effects of both the crude extract and the isolated secondary metabolites were evaluated in cell viability, qRT-PCR assays, flow cytometry analysis and western blotting.
Results: The cell viability assay revealed that extracts from Nemania sp. EL006872 and the isolated secondary compounds had low cytotoxicity. The crude extract, radianspenes C and D, and dahliane D, suppressed expression of mRNA encoding PD-L1 and aromatic hydrocarbon receptor (AhR), and surface expression of PD-L1 protein by cells exposed to benzo[a] pyrene. Radianspenes C and D, and dahliane D, reduced expression of AhR, PD-L1, ICOSL, and GITRL proteins by H1975 lung cancer cells, as well as exerting anti-proliferative effects.
Conclusion: Radianspenes C and D, and dahliane D, bioactive compounds isolated from Nemania sp. EL006872 ELF, have the potential for use as immunotherapy and immunoncology treatments.
Introduction
Exposure to environmental pollutants and tobacco smoke is an important public health problem involving major pollutant benzo[a]pyrene (BaP) (Poirier, 2004; Taş et al., 2019b). Sources of BaP include coal tar (Zieliński et al., 1996), cigarette smoke, automobile exhaust fumes (Tancell et al., 1995), smoke generated by combustion of organic material, and grilled food (Aygün and Kabadayi, 2005). Exposure to BaP causes lung cancer and systemic inflammation (Shi et al., 2017). Lung cancer is the most common cause of cancer-related death worldwide (Gomes et al., 2014). BaP-mediated modulation of gene transcription occurs through activation of the aryl hydrocarbon receptor (AhR) or via DNA damage (Shimizu et al., 2000; Hockley et al., 2007; Vázquez-Gómez et al., 2018). Upon exposure to BaP and tobacco smoke, AhR induces expression of an important immune checkpoint, programmed death ligand 1 (PD-L1) (Wang et al., 2019). Therefore, development of new effective agents or cancer immune therapy treatments is required (Jain et al., 2018).
Lichens, symbiotic organisms comprising fungi and algae (or cyanobacteria), have attracted much attention as a source of therapeutic agents for the treatment of numerous diseases, including cancer (Zhou et al., 2017; Yang et al., 2018b, 2018a; Taş et al., 2019a; Tas et al., 2019; Lee et al., 2021). Similar to endophytes living inside plants, endolichenic fungi (ELF) live inside lichen thalli (Honegger et al., 2013). Many studies have identified secondary metabolites in ELF (Wijeratne et al., 2012, 2010; Wang et al., 2010; Li et al., 2015, 2012; He et al., 2012; Jiao et al., 2015). In recent years, it has been reported that microbes as produce different secondary metabolites, including antioxidant, antiviral, anti-Alzheimer, anti-inflammatory, UV protectant, antimicrobial and anticancer activities (Padhi et al., 2019a; Agrawal et al., 2020). Endolichenic fungi secondary metabolites can be classified into the different chemical groups, steroids, terpenoids, xanthones, quinones, peptides, sulphur-containing chromenones, etc (Yang et al., 2018b; Padhi et al., 2019b). More than 40,000 terpenoid compounds have been isolated from natural sources and, especially, diterpenoids can be found in all areas of life, and are secondary metabolites of fungi and plants (Zhang and Feng, 2022). Due to their structural diversity and bioactivity, diterpenoids may be potential alternative therapies. Studies show that fungal diterpenoids have cytotoxic, anti-inflammatory, antimicrobial, anti-MRSA, antiviral, and antihypertensive properties (Ling et al., 2014; Büschleb et al., 2016; Hu et al., 2020; Min et al., 2020).
Cancer immunotherapy aims to strengthen the human immune system, thereby enabling it to eliminate cancer cells (Li et al., 2016). The fundamental rationale underlying cancer immunotherapy lies in utilization of specific antibodies and T cells that enable the immune system to discriminate the tiniest biochemical differences between cancer and normal cells (Rojas-Martínez et al., 2017). Tumors use multiple immune regulatory mechanisms to inhibit their antitumor immune effects. Immune checkpoints are inhibitory pathways that physiologically balance co-stimulatory pathways to fine-tune immune responses. Regarding the two components of an immune checkpoint, molecules expressed by immune cells are often referred to as immune checkpoint receptors, while those expressed by antigen-presenting cells, tumor cells or other cell types are called immune checkpoint ligands (Foy et al., 2016; Gibney et al., 2016). Overexpression of immune checkpoint ligands by tumor cells affects tumor-specific T cell immunity in the cancer microenvironment. Since most tumor immune escape mechanisms based on these checkpoints block effector cell functions, antitumor immunity can be restored by antibodies that block inhibitory receptor-ligand interactions, thereby inactivating the immune checkpoints (Carosella et al., 2015).
In this study, the aim was to identify the immunotherapeutic potential of Nemania sp. EL006872 extracts, and its diterpenoids metabolites, radianspenes C and D, and dahliane D, particuraly in the context of immune checkpoint inhibition. To the best of our knowledge, few studies have examined the efficacy of radianspenes and dahlianes as potential immunotherapy agents.
Materials and methods
Sample collection, isolation and identification of the endolichenic fungus
The lichen samples of Bryoria fuscescens (Gyelnik) Brodo and D. Hawksw were collected in 2019 during the field trips in Mt. Uludağ (40˚06’00.73″N, 29˚16’59.79″E), Bursa, Turkey, organized by Prof. Sesal from Dept. of Plant Diseases and Microbiology, Marmara University, Istanbul, Turkey. Voucher samples (KoLRI 052660) has been deposited at the Korean Lichen and Allied Bioresource Center (KOLABIC) in the Korean Lichen Research Institute (KoLRI), Sunchon National University, Korea (https://cc.aris.re.kr/kolabic). Endolichenic fungi were isolated with the surface sterilization method (Guo et al., 2003).
Fungus internal transcribed spacer sequencing conducted as already depicted (Yang et al., 2018b). The endolichenic fungus is cultured on potato dextrose agar (PDA) (BD Difco, Sparks, MD, United States). DNA was extracted from ELFs using a DNeasy Plant Mini Kit following the manufacturer’s protocols (Qiagen, Hilden, Germany). The ITS (internal transcribed spacer) region of the rDNA was amplified with the common using primers ITS1F (5′-CTTGGTCATTTAGAGGAAGTAA-3′) (Gardes and Bruns, 1993) and LR5 (5′-ATCCTGAGGGAAACTTC-3′) (Vilgalys and Hester, 1990). The strain used in this study (EL006872), was identified as Nemania sp. by the BLAST search of the ITS sequence, which showed 99.81% similarity against Nemania sp. genotype 184 (GenBank Accession No. JQ761782.1). The ITS sequence of Nemania sp. EL006872 is available in Supplementary Table S1.
Pure culture and metabolites extraction
Potato dextrose agar (PDA) (BD Difco, Sparks, MD, United States) powder (39 g) was prepared into 1 L distilled water, which was then boiled and mixed to dissolve the powder. The mixture was autoclaved. The autoclaved PDA solution was cooled down to 55–60°C and then directly transferred into the petri dishes. Petri dishes were cooled to room temperature. ELFs were transferred to be cultured on agar in each petri dish. The dishes were incubated at 25°C for 3–4 weeks. ELF mycelia were grown on PDA and then frozen with agar and lyophilized. The lyophilization was separated into water. Then, acetone was added to samples tubes, and the tubes were shaken for around 2 h. Each sample was then filtered to separate from solid particles. Crude extracts of ELFs were then obtained by rotary evaporator. Finally, the crude extracts were dissolved in 100% DMSO for use.
Isolation and structure elucidation
The dried crude extract (2.7 g) was suspended in water, then successively extracted with n-hexane and ethyl acetate (EtOAc). A Waters 600 HPLC system (Waters Co., Milford, MA, United States) equipped with a Hector-M C18 column (250 mm × 10 mm, 5 μM, RS Tech, Daejeon, Korea) or a Spursil C18 EP column (250 mm × 10.0 mm, 5 μM, Dikma Technologies, Foothill Ranch, CA, United States) was used for the purification of compounds 1–3 from the EtOAc fraction. The EtOAc fraction (78.9 mg) was further separated by preparative HPLC (Hector C18 column, 4 ml/min, MeCN-0.1% formic acid in H2O 20:80 → 80:20) into five subfractions (E1– E5). Compounds 1 (1.0 mg, tR = 10.0 min) and 2 (1.3 mg, tR = 8.0 min) were purified from the subtraction E4 by preparative HPLC (Spursil C18 EP column, 4 ml/min, MeCN-0.1% formic acid in H2O 45:55 → 58:42). Compound 3 (0.7 mg, tR = 11.5 min) was obtained from the subfraction E4 by preparative HPLC (Spursil C18 EP column, 4 ml/min, MeCN-0.1% formic acid in H2O 45:55 → 58:42). NMR spectra were obtained using a Bruker Avance III HD 500 spectrometer (Bruker BioSpin, Billerica, MA, United States) (Supplementary Table S2; Supplementary Figures S1-S13).
Cell culture
H1975 non-small lung cancer cell line was used in this research. H1975 cell was cultured in RPMI (GenDepot, Katy, TX, United States) supplemented with 10% fetal bovine serum (GenDepot, Katy, TX, United States) and 1% penicillin streptomycin solution. Cells were incubated in 5% CO2 in a humidified atmosphere at 37°C.
Cell viability assay
Extract and pure compounds were dissolved in DMSO (Sigma-Aldrich, St. Louis, MO, United States). Cells were seeded at a density of 3 x 103 cells/well in 96-well plates, grown overnight, and then treated with crude extract and pure compounds. After incubation, 15 μL methyl thiazolyl tetrazolium (MTT) reagent (Sigma-Aldrich) was added to each well, and the samples were incubated for an additional 4 h. After 4 h, the supernatants were removed, and formazan crystals were dissolved in 150 µL DMSO. Absorbance was measured at 570 nm and was determined using a microplate reader with Gen5 (v2.03.1) software (BioTek, Winooski, VT, United States).
Clonogenic assay
H1975 cells were seeded at a density of 1000–1500 cells/well in RPMI 1640 and incubated overnight. After 72 h, media containing the crude extract and indicated compounds or DMSO was replaced with fresh medium for 12 days. Colonies were fixed with methanol, and stained with 0.5% crystal violet. Then, the plating efficiency and survival rate of the control group and treatment group cells were determined. Next, the plating efficiency of the control group and treatment groups were determined (Le et al., 2022).
Quantitative reverse-transcription PCR
Quantitative RT-PCR (qRT-PCR) was conducted as already depicted. H1975 were plated at a density of 2 x 105 cells/well on 6-well plate and grown overnight. Cells were treated with crude extract, pure compounds, and benzo[a]pyrene or DMSO. Total RNA was isolated from H1975 cells using RNAiso Plus (TaKaRa, Otsu, Japan). 1 mg of RNA was converted to cDNA using M-MLV reverse transcriptase (Invitrogen, Carlsbad, CA, United States). qPCR was performed using SYBR Green (Enzynomics, Seoul, Korea). qRT-PCR reactions and analyses were performed on a CFX instrument (Bio-Rad, Hercules, CA, United States). Primers used for qRT-PCR were as follows: GAPDH (forward) 5′-atcaccatcttccaggagcga-3′ and (reverse) 5′-agttgtcatggatgaccttggc-3`; PD-L1 (forward) 5`-ggagattagatcctgaggaaaacca-3` and (reverse) 5`-aacggaagatgaatgtcagtgcta-3`; AhR (forward) 5`-attgtgccgagtcccatatc-3` and (reverse) 5`-aagcaggcgtgcattagact-3`.
Surface protein expression
H1975 were plated at a density of 2 × 105 cells/well on a 6-well plate and grown overnight. Then, cells were treated with crude extract, radianspenes C and D, and dahliane D 4 h prior to exposure benzo[a]pyrene (1 µM) and then cells were incubated for 72 h. H1975 cell line was incubated for 72 h and collected in PBS by trypsin digestion. After washing three times, cell pellets were resuspended in 2% BSA and 100 μl aliquot (1 cells × 106 cells) was used for antibody labeling with anti-PD-L1 antibody (Cell signaling, #13684) at 4 °C for 30 min in the dark. After washing with FACS buffer twice and cell was incubated with secondary antibody anti-Rabbit IgG (H + L) (Cell signaling, Alexa flour 488 conjugate, #4412) at 4 °C for 30 min in the dark. After washing steps, the labeled cells were analyzed by flow cytometry using Cytoflex flow cytometer (Beckman Coulter Life Sciences, Indianapolis, IN, United States) and CytExpert 2.0.0.152 software.
Western blotting
Cells were cultured in a 6-well plate for 12 h, treated with 7.5, 15, and 30 µM concentrations of radianspenes C and D, and dahliane D for 72 h, washed twice with cold PBS, and lysed in lysis buffer. Primary antibodies (PD-L1 (Cell signaling, #13684), ICOSL (Sigma-Aldrich, WH0023308M1), GITRL (Abcam, ab25948), AhR (Cell signaling, #83200), and GAPDH (Cell signaling, #5174)) against were used to probe membranes. After membranes incubated with secondary antibodies (Thermo Fisher Scientific) and detected with using an Immobilon Western Chemiluminescent HRP Substrate Kit (Merck Millipore, Germany), and luminescence imaging (iBright™ FL1000 Imaging System, Thermo Fisher Sciences). Multi-Gauge 3.0 was used to assess band densities, which were then normalized to GAPDH levels in each sample. The values are given in arbitrary densitometric units that correlate to the signal intensities.
Results
Nemania sp. EL006872 crude extract shows immune checkpoint inhibitory activity
Figure 1A shows the Nemania sp. EL006872 culture. First of all, cell viability assay using acetonic extract of Nemania sp. EL006872 was performed to determine the cytotoxic activity of the extract (10 μg/mL). As a result, acetonic extracts of the Nemania sp. EL006872 that maintained H1975 cell viability were tested for future experiments (Figure 1B).
FIGURE 1. Nemania sp. EL006872 inhibits expression of PD-L1 and AhR. (A) Images of the isolated endolichenic fungus EL006872. (B) Effect of Nemania sp. EL006872 crude extract on the viability of H1975 cells. (C,D) Effect of Nemania sp. EL006872 crude extract on PD-L1 and aromatic hydrocarbon receptor (AhR) mRNA in benzo[a]pyrene (BaP) exposed H1975 cells. (E,F) Effects of Nemania sp. EL006872 crude extract on surface protein level of PD-L1 in BaP exposed H1975 cells. MFI: mean fluorescence intensity. Data are presented as the mean ± S.D. (standard deviation); n = 3. *p < 0.05; **p < 0.01; ***p < 0.001; NS, no significant difference compared with the BaP-treated group or between indicated group.
Exposure to benzo[a]pyrene (BaP) increases expression of PD-L1 by lung epithelial cells, likely mediated via AhR (Wang et al., 2019). Recent reports suggest that aromatic hydrocarbon receptor (AhR) interacts with metabolites and derivatives such as kynurenine (Esser, 2016; Kawajiri and Fujii-Kuriyama, 2017; Gutiérrez-Vázquez and Quintana, 2018). AhR induces expression by BaP. Overexpression of AhR in many cancers triggers production of toxic metabolites via overexpression of CYP1A1 and CYP1B1 (Harrigan et al., 2004). H1975 non-small lung cancer cell line was used because previous studies show that it overexpresses PD-L1 (Chen et al., 2015; Yan et al., 2016). A hall mark of cancer is that the cells can evade attack by host immune cells. Carcinoma cells may express many immune inhibitory signaling pathways that induce immune cell apoptosis and dysfunction. Programmed death ligand-1 (PD-L1) binds to programmed death-1 (PD-1) expressed by dendritic cells, B cells, T cells, and the natural killer T cells to inhibit their anticancer effects (Chen et al., 2016).
Next, the effects of Nemania sp. EL006872 crude extract on expression of AhR and PD-L1 mRNA in BaP exposed H1975 cells were examined. qRT-PCR revealed that expression of PD-L1 and AhR mRNA in BaP exposed H1975 cell was downregulated by pretreatment of acetone extracts of Nemania sp. EL006872 (Figures 1C,D). Subsequently, in order to observe the surface protein expression, flow cytometry was used to examine the effects of Nemania sp. EL006872 extract, on BaP-induced expression of PD-L1 by H9175 cells. The results showed that increased surface protein level of PD-L1 in BaP exposed condition were diminished by EL006872 extract pretreatment (Figures 1E,F).
Effect of isolated diterpenes on the transcriptional regulator AhR and the immune checkpoint marker PD-L1 in H1975 cells exposed to BaP
LC-MS analysis on the crude extract of Nemania sp. EL006872 revealed the presence of multiple compounds (Figure 2A). Successive chromatography yielded three purified compounds, which were identified as radianspenes C and D, and dahliane D (Figure 2B) by comparing their NMR spectra with those reported in the literature (Ou et al., 2012; Wu et al., 2015). Although the LC-MS chromatogram showed other major peaks, they were not able to be purified due to the trace amounts. None of these isolates were cytotoxic to H1975 lung cancer cells up to 30 μM (Supplementary Figure S1); therefore, concentrations of 7.5, 15, and 30 μM (∼2.5, 5, 10 μg/mL) were used in subsequent biological assays.
FIGURE 2. Chemical structures of radianspenes C and D, and dahliane D. (A) LC-MS base peak ion chromatogram (negative ion mode) of the Nemania sp. EL006872 crude extract. The isolated compounds were denoted. It should be noted that the intensities of chromatographic peaks do not represent absolute quantity of each compound, because the MS signal intensity is heavily affected by ionization efficiency of each molecule. (B) Chemical structures of radianspenes C and D, and dahliane D.
To evaluate the biological activity of isolated compounds, the expression of AhR and PD-L1 mRNA level were checked as shown in Figures 1C,D. Unexpectedly, our results showed that all of three compounds, radianspenes C and D, and dahliane D, reduced the expression of the AhR and PD-L1 mRNA (Figures 3A,B). To further confirmation and characterization, flow cytometry analysis was performed to investigate the bioactive compounds on cell surface expression of PD-L1 upon exposure of BaP in H1975 cells. The results showed that radianspenes C and D, and dahliane D, downregulated PD-L1 surface protein level in a dose-dependent manner on BaP exposed condition (Figures 4A,B).
FIGURE 3. Radianspenes C and D, and dahliane D, suppress benzo[a]pyrene (BaP)-induced expression of AhR and PD-L1 mRNA. H1975 cells were treated with radianspene C and, D and dahliane D, at 7.5, 15, and 30 µM ( ∼ 2.5, 5, 10 µg/mL) 4 h prior to exposure benzo[a]pyrene (1 µM) and then cells were incubated for 72 h, AhR (A) and PD-L1 (B) mRNA level was measured using qRT-PCR. *p < 0.05; **p < 0.01; ***p < 0.001; NS, no significant difference when compared with the BaP-treated group or between indicated group.
FIGURE 4. Evaluated the the PD-L1 surface protein activity on benzo[a]pyrene induction condition, treated with radianspenes C and D, and dahliane D. H1975 cells were treated with radianspenes C and, D and dahliane D, at 7.5, 15, and 30 µM ( ∼2.5, 5, 10 µg/mL) 4 h prior to exposure benzo[a]pyrene (1 µM) and then cells were incubated for 72 h, and PD-L1 surface protein level was measured using flow cytometry. Relative PD-L1 MFI value was determined by flow cytometry (A,B). MFI: mean fluorescence intensity. *p < 0.05; **p < 0.01; ***p < 0.001; NS, no significant difference when compared with the BaP-treated group or between indicated group.
Radianspenes C and D, and dahliane D, reduce expression of multiple immune checkpoint proteins
Next, the inhibitory effects of ELF-derived compounds on expression of multiple immune checkpoint markers (i.e., PD-L1, ICOSL, and GITRL) were evaluated. Expression of PD-L1, GITRL, and ICOSL were downregulated by radianspenes C and D, and dahliane D, in a dose-dependent manner. In addition, the expression of the transcriptional regulator AhR was also investigated. The level of AhR protein decreased upon treat to ELF-derived compounds. Thus, radianspenes C and D, and dahliane D, exert potent inhibitory effects against multiple immune checkpoints (Figure 5).
FIGURE 5. Effect of radianspenes C and D, and dahliane D, on expression of AhR, PD-L1, ICOSL, and GITRL. The level of AhR, PD-L1, ICOSL and GITRL protein by radianspenes C (A,B) and D (C,D), and dahliane D (E,F) treatment were shown. Data are presented as the mean ± SD, n = 3. *p < 0.05; **p < 0.01; ***p < 0.001 compared with the DMSO-treated group.
Radianspenes C and D, and dahliane D, have anti-proliferative effects in H1975 cells
To investigate the anti-proliferative potential of the ELF-derived compounds in vitro, a clonogenic assay was performed in H1975 cells. Cancer cell proliferation and tumor growth are the defining features of cancer progression (Taş et al., 2021). The proliferative capacity of the H1975 cells were suppressed significantly by radianspenes C and D, and dahliane D, in a dose-dependent manner (Figure 6). Thus, the diterpenoid compounds radianspenes C and D, and dahliane D, show anti-proliferative activity. The highest concentration of radianspene C (30 μM) inhibited colony formation to the greatest extent.
FIGURE 6. Radianspenes C and D, and dahliane D, show anti-proliferative effects against H1975 cells. (A) Radianspene C, (B) radianspene D, and (C) dahliane D show anti-proliferative activity in a clonogenic assay. Representative images are shown, alongside histograms showing the percentage of colony area in each condition. Data are presented as the mean ± SD, n = 3. *p < 0.05; **p < 0.01; ***p < 0.001 compared with the DMSO-treated group.
Discussion
Here, the effects of an ELF extract and isolated secondary metabolites on immune checkpoints in non-small lung cancer cells were investigated. This study identified (Figure 7) 1) the ELF species Nemania sp. EL006872 was isolated from Bryoria fuscescens (Gyelnik) Brodo and D. Hawksw; 2) Nemania sp. EL006872 showed immune checkpoint inhibition activity through suppressing AhR and PD-L1 mRNA and surface protein expression in BaP exposed H1975 cells; 3) radianspenes C and D, and dahliane D were isolated from Nemania sp. EL006872 crude extract and found to have bioactivity; 4) radianspenes C and D, and dahliane D suppresses the expression of multiple immune checkpoints including PD-L1, ICOSL, and GITRL; 5) radianspenes C and D, and dahliane D showed anti-proliferative activity.
FIGURE 7. Schematic overview of the immune checkpoint inhibitory activity of diterpenoid compounds isolated from Nemania sp. EL006872.
Radianspenes C and D, and dahliane D, are secondary metabolites (diterpenoids) found in fungi (Zhang and Feng, 2022). A previous study showed that radianspene C from Coprinus radians showed cytotoxic effect on MDA-MB-435 human breast cancer cells with an IC50 value of 0.91 μM (Ou et al., 2012). Another study isolated the fungus Verticillium dahliae from the intestine of the insect Coridius chinensis, and identified new guanacastane-type diterpenoids (dahlianes A–K) (Wu et al., 2015; Zhang et al., 2019). Previously, dahlianes A–D were tested against human cancer cell lines (HepG2, MCF-7, and HT-29) and found to be non-cytotoxic, even at a concentration of 50 µM (Wu et al., 2015). Here, it was found that none of the secondary metabolites were toxic effects to H1975 cells at concentrations up to 30 μM (Supplementary Figure S1). The non-cytotoxic effect of radianspenes C, D and dahliane D isolated from the extract on cell viability is consistent with the results of the crude extract. Our results show that the crude extract and pure components can be used safely at a concentration of 10 μg/mL.
Surgery, radiotherapy, and chemotherapy are the standard treatments for cancer; however, their effects are limited, necessitating development of new therapeutic options such as antitumor immunotherapy (Lemjabbar-Alaoui et al., 2015; Jain et al., 2018). Studies carried out under the umbrella of cancer immunotherapy have led to development of strategies that prevent inactivation of T cells by blocking immune checkpoints with an antibody (Pardoll, 2012). In our study, focuses were made on the PD-1/PD-L1, ICOS/ICOSL, and GITR/GITRL pathways in cancer cells. The most studied and well known mechanism is inhibition of PD-L1 on tumor cells, and the PD-1 and CTLA-4 signaling pathways in T cell cells (Kosanić et al., 2013; Borghaei et al., 2015; Horn et al., 2018). CTLA-4 and PD-1 pathway inhibitors include Ipilimumab, Tremelimumab, Pembrolizumab, Nivolumab, Pidilizumab, Durvalumab, and Atezolimab (Buchbinder and Desai, 2016). Previous studies show that PD-L1 is induced by BaP via AhR (Wang et al., 2019). Here, crude extract from Nemania sp. EL006872, and isolated secondary metabolites, inhibit expression of PD-L1 and AhR on non-small lung cancer cell exposed to BaP.
The ICOS/ICOSL (CD275/CD278) pathway regulates the Treg population and, subsequently, tumor development (Amatore et al., 2020). Expression of ICOS/ICOSL regulates the CD4+, CD8+, and FoxP3+ regulatory effector cell populations. Overexpression of ICOS ligand is associated with reduced patient survival (Burmeister et al., 2008; Marinelli et al., 2018). Many studies examined molecules targeting different immune checkpoints. For example, GSK3359609, JTX-2011, MEDI-570, and KY1044 inhibit ICOS (Solinas et al., 2020). Another immune checkpoint marker is GITRL (glucocorticoid-induced tumor necrosis factor receptor-related protein ligand), which plays a role in immune cell activation, survival and signaling (Wang et al., 2021). Targeting the GITRL-GITR pathway activates CD4+ and CD8+ T cells, thereby promoting tumor suppression (Durham et al., 2017). Studies on the interaction between immune checkpoint signaling pathways and other signaling pathways, and its inhibition in different immunological diseases, are continuing.
Conclusion
The ELF extract inhibit immune checkpoint ligands in cancer cells exposed to BaP, an environmental pollutant. Radianspenes C and D, and dahliane D, suppress multiple immune checkpoint markers in lung cancer cells. The Nemania sp. EL006872 crude extract and its secondary metabolites have the potential for use as support therapies, and to act as templates for development of new target molecules to overcome drug resistance. Our study shows that radianspenes C and D, and dahliane D, can be isolated from ELF and used to conduct research into the treatment of cancer and other diseases related to immune checkpoints. Future studies will examine the molecular mechanisms of action and in vivo effects of Nemania sp. EL006872 secondary metabolites on immunoregulation and tumor growth.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Author contributions
MV and HK conceived and designed the experiments. MV, S-MK, İT, CG, RZ, SP, and S-YP performed the biological experiments. MV, S-MK, and İT prepared the acetonic extract samples for screening. HP and KBK isolated the single compounds. NCS and J-SH contributed materials. MV and HK analyzed the data and wrote the manuscript. All authors read and approved the final manuscript.
Funding
This work was supported by the National Research Foundation of Korea grant (NRF-2020R1C1C1007832, NRF-2018K1A3A1A39087314) funded by the Korea government (MSIP) and the Scientific and Technological Research Council of Turkey (TÜBİTAK), grant no 218S752.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fphar.2022.986946/full#supplementary-material
Abbreviations
AhR, Aryl hydrocarbon receptor; BaP, benzo[a]pyrene; DMSO, Dimethyl sulfoxide; ELF, endolichenic fungi; GITRL, Glucocorticoid-induced TNFR-related protein ligand; ICOSL, Inducible T Cell Costimulator Ligand; ITS, internal transcribed spacer; MFI, Mean Fluorescence Intensity; PDA, potato dextrose agar; PD-L1, programmed death-ligand 1.
References
Agrawal, S., Deshmukh, S. K., Reddy, M. S., Prasad, R., and Goel, M. (2020). Endolichenic fungi: A hidden source of bioactive metabolites. South Afr. J. Bot. 134, 163–186. doi:10.1016/j.sajb.2019.12.008
Amatore, F., Gorvel, L., and Olive, D. (2020). Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy. Expert Opin. Biol. Ther. 20, 141–150. doi:10.1080/14712598.2020.1693540
Aygün, S. F., and Kabadayi, F. (2005). Determination of benzo[a]pyrene in charcoal grilled meat samples by HPLC with fluorescence detection. Int. J. Food Sci. Nutr. 56, 581–585. doi:10.1080/09637480500465436
Borghaei, H., Paz-Ares, L., Horn, L., Spigel, D. R., Steins, M., Ready, N. E., et al. (2015). Nivolumab versus docetaxel in advanced nonsquamous non–small-cell lung cancer. N. Engl. J. Med. 373, 1627–1639. doi:10.1056/nejmoa1507643
Buchbinder, E. I., and Desai, A. (2016). CTLA-4 and PD-1 pathways similarities, differences, and implications of their inhibition. Am. J. Clin. Oncol. 39, 98–106. doi:10.1097/COC.0000000000000239
Burmeister, Y., Lischke, T., Dahler, A. C., Mages, H. W., Lam, K.-P., Coyle, A. J., et al. (2008). ICOS controls the pool size of effector-memory and regulatory T cells. J. Immunol. 180, 774–782. doi:10.4049/jimmunol.180.2.774
Büschleb, M., Dorich, S., Hanessian, S., Tao, D., Schenthal, K. B., and Overman, L. E. (2016). Synthetic strategies toward natural products containing contiguous stereogenic quaternary carbon atoms. Angew. Chem. Int. Ed. Engl. 55, 4156–4186. doi:10.1002/ANIE.201507549
Carosella, E. D., Ploussard, G., LeMaoult, J., and Desgrandchamps, F. (2015). A systematic review of immunotherapy in urologic cancer: Evolving roles for targeting of CTLA-4, PD-1/PD-L1, and HLA-G. Eur. Urol. 68, 267–279. doi:10.1016/j.eururo.2015.02.032
Chen, J., Jiang, C. C., Jin, L., and Zhang, X. D. (2016). Regulation of PD-L1: A novel role of pro-survival signalling in cancer. Ann. Oncol. 27, 409–416. doi:10.1093/annonc/mdv615
Chen, N., Fang, W., Zhan, J., Hong, S., Tang, Y., Kang, S., et al. (2015). Upregulation of PD-L1 by EGFR activation mediates the immune escape in EGFR-driven NSCLC: Implication for optional immune targeted therapy for NSCLC patients with EGFR mutation. J. Thorac. Oncol. 10, 910–923. –923. doi:10.1097/JTO.0000000000000500
Durham, N. M., Holoweckyj, N., MacGill, R. S., McGlinchey, K., Leow, C. C., and Robbins, S. H. (2017). GITR ligand fusion protein agonist enhances the tumor antigen-specific CD8 T-cell response and leads to long-lasting memory. J. Immunother. Cancer 5, 47–12. doi:10.1186/s40425-017-0247-0
Esser, C. (2016). “The aryl hydrocarbon receptor in immunity: Tools and potential,” in Methods in molecular biology (Totowa, New Jersey, United States: Humana Press), 239–257. doi:10.1007/978-1-4939-3139-2_16
Foy, S. P., Mandl, S. J., Cruz, T. D., Cote, J. J., Gordon, E. J., Trent, E., et al. (2016). Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells. Cancer Immunol. Immunother. 3, 537–549. doi:10.1007/s00262-016-1816-7
Gardes, M., and Bruns, T. D. (1993). ITS primers with enhanced specificity for basidiomycetes - application to the identification of mycorrhizae and rusts. Mol. Ecol. 2, 113–118. doi:10.1111/J.1365-294X.1993.TB00005.X
Gibney, G. T., Weiner, L. M., and Atkins, M. B. (2016). Predictive biomarkers for checkpoint inhibitor-based immunotherapy. Lancet. Oncol. 17, e542–e551. doi:10.1016/S1470-2045(16)30406-5
Gomes, M., Teixeira, A. L., Coelho, A., Araújo, A., and Medeiros, R. (2014). The role of inflammation in lung cancer. Basel: Springer, 1–23. doi:10.1007/978-3-0348-0837-8_1
Guo, L. D., Huang, G. R., Wang, Y., He, W. H., Zheng, W. H., and Hyde, K. D. (2003). Molecular identification of white morphotype strains of endophytic fungi from Pinus tabulaeformis. Mycol. Res. 107, 680–688. doi:10.1017/S0953756203007834
Gutiérrez-Vázquez, C., and Quintana, F. J. (2018). Regulation of the immune response by the aryl hydrocarbon receptor. Immunity 48, 19–33. doi:10.1016/j.immuni.2017.12.012
Harrigan, J. A., Vezina, C. M., Mcgarrigle, B. P., Ersing, N., Box, H. C., Maccubbin, A. E., et al. (2004). DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene. Toxicol. Sci. 77, 307–314. doi:10.1093/toxsci/kfh030
He, J. W., Chen, G. D., Gao, H., Yang, F., Li, X. X., Peng, T., et al. (2012). Heptaketides with antiviral activity from three endolichenic fungal strains Nigrospora sp., Alternaria sp. and Phialophora sp. Fitoterapia 83, 1087–1091. doi:10.1016/j.fitote.2012.05.002
Hockley, S. L., Arlt, V. M., Brewer, D., Te Poele, R., Workman, P., Giddings, I., et al. (2007). AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. Chem. Res. Toxicol. 20, 1797–1810. doi:10.1021/TX700252N/SUPPL_FILE/TX700252N-FILE004
Honegger, R., Axe, L., and Edwards, D. (2013). Bacterial epibionts and endolichenic actinobacteria and fungi in the Lower Devonian lichen Chlorolichenomycites salopensis. Fungal Biol. 117, 512–518. doi:10.1016/j.funbio.2013.05.003
Horn, L., Mansfield, A. S., Szczęsna, A., Havel, L., Krzakowski, M., Hochmair, M. J., et al. (2018). First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N. Engl. J. Med. 379, 2220–2229. doi:10.1056/nejmoa1809064
Hu, Y. J., Li, L. X., Han, J. C., Min, L., and Li, C. C. (2020). Recent advances in the total synthesis of natural products containing eight-membered carbocycles (2009-2019). Chem. Rev. 120, 5910–5953. doi:10.1021/ACS.CHEMREV.0C00045/ASSET/IMAGES/MEDIUM/CR0C00045_0044
Jain, P., Jain, C., and Velcheti, V. (2018). Role of immune-checkpoint inhibitors in lung cancer. Ther. Adv. Respir. Dis. 12, 1753465817750075. doi:10.1177/1753465817750075
Jiao, Y., Li, G., Wang, H. Y., Liu, J., Li, X. B., Zhang, L. L., et al. (2015). New metabolites from endolichenic fungus pleosporales sp. Chem. Biodivers. 12, 1095–1104. doi:10.1002/cbdv.201400279
Kawajiri, K., and Fujii-Kuriyama, Y. (2017). The aryl hydrocarbon receptor: A multifunctional chemical sensor for hostdefense and homeostatic maintenance. Exp. Anim. 66, 75–89. doi:10.1538/EXPANIM.16-0092
Kosanić, M., Manojlović, N., Janković, S., Stanojković, T., and Ranković, B. (2013). Evernia prunastri and Pseudoevernia furfuraceae lichens and their major metabolites as antioxidant, antimicrobial and anticancer agents. Food Chem. Toxicol. 53, 112–118. doi:10.1016/j.fct.2012.11.034
Le, T. C., Pulat, S., Lee, J., Kim, G. J., Kim, H., Lee, E. Y., et al. (2022). Marine depsipeptide nobilamide i inhibits cancer cell motility and tumorigenicity via suppressing epithelial-mesenchymal transition and MMP2/9 expression. ACS Omega 7, 1722–1732. doi:10.1021/ACSOMEGA.1C04520/ASSET/IMAGES/LARGE/AO1C04520_0010
Lee, S., Suh, Y. J., Yang, S., Hong, D. G., Ishigami, A., Kim, H., et al. (2021). Neuroprotective and anti-inflammatory effects of evernic acid in an MPTP-induced Parkinson’s disease model. Int. J. Mol. Sci. 22, 2098–2118. doi:10.3390/ijms22042098
Lemjabbar-Alaoui, H., Hassan, O. U. I., Yang, Y. W., and Buchanan, P. (2015). Lung cancer: Biology and treatment options. Biochim. Biophys. Acta 1856, 189–210. doi:10.1016/J.BBCAN.2015.08.002
Li, G., Wang, H., Zhu, R., Sun, L., Wang, L., Li, M., et al. (2012). Phaeosphaerins A-F, cytotoxic perylenequinones from an endolichenic fungus, Phaeosphaeria sp. J. Nat. Prod. 75, 142–147. doi:10.1021/np200614h
Li, X. B., Zhou, Y. H., Zhu, R. X., Chang, W. Q., Yuan, H. Q., Gao, W., et al. (2015). Identification and biological evaluation of secondary metabolites from the endolichenic fungus aspergillus versicolor. Chem. Biodivers. 12, 575–592. doi:10.1002/cbdv.201400146
Li, Y., Li, F., Jiang, F., Lv, X., Zhang, R., Lu, A., et al. (2016). A mini-review for cancer immunotherapy: Molecular understanding of PD-1/PD-L1 pathway & translational blockade of immune checkpoints. Int. J. Mol. Sci. 17, E1151. doi:10.3390/ijms17071151
Ling, C., Fu, L., Gao, S., Chu, W., Wang, H., Huang, Y., et al. (2014). Design, synthesis, and structure-activity relationship studies of novel thioether pleuromutilin derivatives as potent antibacterial agents. J. Med. Chem. 57, 4772–4795. doi:10.1021/jm500312x
Marinelli, O., Nabissi, M., Morelli, M. B., Torquati, L., Amantini, C., and Santoni, G. (2018). ICOS-L as a potential therapeutic target for cancer immunotherapy. Curr. Protein Pept. Sci. 19, 1107–1113. doi:10.2174/1389203719666180608093913
Min, L., Liu, X., and Li, C. C. (2020). Total synthesis of natural products with bridged bicyclo[m.n.1] ring systems via type II [5 + 2] cycloaddition. Accounts Chem. Res. 53, 703–718. doi:10.1021/ACS.ACCOUNTS.9B00640/ASSET/IMAGES/LARGE/AR9B00640_0014
Ou, Y. X., Li, Y. Y., Qian, X. M., and Shen, Y. M. (2012). Guanacastane-type diterpenoids from Coprinus radians. Phytochemistry 78, 190–196. doi:10.1016/J.PHYTOCHEM.2012.03.002
Padhi, S., Masi, M., Cimmino, A., Tuzi, A., Jena, S., Tayung, K., et al. (2019b). Funiculosone, a substituted dihydroxanthene-1, 9-dione with two of its analogues produced by an endolichenic fungus Talaromyces funiculosus and their antimicrobial activity. Phytochemistry 157, 175–183. doi:10.1016/J.PHYTOCHEM.2018.10.031
Padhi, S., Masi, M., Panda, S. K., Luyten, W., Cimmino, A., Tayung, K., et al. (2019a). Antimicrobial secondary metabolites of an endolichenic Aspergillus Niger isolated from lichen thallus of Parmotrema ravum. Nat. Prod. Res. 34, 2573–2580. doi:10.1080/14786419.2018.1544982
Pardoll, D. M. (2012). The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252–264. doi:10.1038/NRC3239
Poirier, M. C. (2004). Chemical-induced DNA damage and human cancer risk. Nat. Rev. Cancer 4, 630–637. doi:10.1038/nrc1410
Rojas-Martínez, A., Rangel-Sosa, M. M., and Aguilar-Córdova, E. (2017). Immunotherapy and gene therapy as novel treatments for cancer. Colomb. Med. 48, 138–147. doi:10.25100/cmv48i3.2997
Shi, Q., Godschalk, R. W. L., and van Schooten, F. J. (2017). Inflammation and the chemical carcinogen benzo[a]pyrene: Partners in crime. Mutat. Res. 774, 12–24. doi:10.1016/j.mrrev.2017.08.003
Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., et al. (2000). Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U. S. A. 97, 779–782. doi:10.1073/PNAS.97.2.779
Solinas, C., Gu-Trantien, C., and Willard-Gallo, K. (2020). The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy. ESMO Open 5, e000544. doi:10.1136/esmoopen-2019-000544
Tancell, P. J., Rhead, M. M., Trier, C. J., Bell, M. A., and Fussey, D. E. (1995). The sources of benzo[a]pyrene in diesel exhaust emissions. Sci. Total Environ. 162, 179–186. doi:10.1016/0048-9697(95)04453-8
Taş, İ., Han, J., Park, S. Y., Yang, Y., Zhou, R., Gamage, C. D. B., et al. (2019a). Physciosporin suppresses the proliferation, motility and tumourigenesis of colorectal cancer cells. Phytomedicine 56, 10–20. doi:10.1016/j.phymed.2018.09.219
Taş, İ., Varlı, M., Son, Y., Han, J., Kwak, D., Yang, Y., et al. (2021). Physciosporin suppresses mitochondrial respiration, aerobic glycolysis, and tumorigenesis in breast cancer. Phytomedicine. 91, 153674. doi:10.1016/J.PHYMED.2021.153674
Tas, I., Yildirim, A. B., Ozkan, E., Ozyigitoglu, G. C., Yavuz, M. Z., and Turker, A. U. (2019). Biological evaluation and phytochemical profiling of some lichen species. Acta Aliment. 48, 457–465. doi:10.1556/066.2019.48.4.7
Taş, İ., Zhou, R., Park, S. Y., Yang, Y., Gamage, C. D. B., Son, Y. J., et al. (2019b). Inflammatory and tumorigenic effects of environmental pollutants found in particulate matter on lung epithelial cells. Toxicol. Vitro 59, 300–311. doi:10.1016/j.tiv.2019.05.022
Vázquez-Gómez, G., Rocha-Zavaleta, L., Rodríguez-Sosa, M., Petrosyan, P., and Rubio-Lightbourn, J. (2018). Benzo[a]pyrene activates an AhR/Src/ERK axis that contributes to CYP1A1 induction and stable DNA adducts formation in lung cells. Toxicol. Lett. 289, 54–62. doi:10.1016/j.toxlet.2018.03.012
Vilgalys, R., and Hester, M. (1990). Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species. J. Bacteriol. 172, 4238–4246. doi:10.1128/jb.172.8.4238-4246.1990
Wang, F., Chau, B., West, S. M., Kimberlin, C. R., Cao, F., Schwarz, F., et al. (2021). Structures of mouse and human GITR–GITRL complexes reveal unique TNF superfamily interactions. Nat. Commun. 12 (1 12), 1378–1379. doi:10.1038/s41467-021-21563-z
Wang, G. Z., Zhang, L., Zhao, X. C., Gao, S. H., Qu, L. W., Yu, H., et al. (2019). The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy. Nat. Commun. 10, 1125–1213. doi:10.1038/s41467-019-08887-7
Wang, Y., Zheng, Z., Liu, S., Zhang, H., Li, E., Guo, L., et al. (2010). Oxepinochromenones, furochromenone, and their putative precursors from the endolichenic fungus Coniochaeta sp. J. Nat. Prod. 73, 920–924. doi:10.1021/np100071z
Wijeratne, E. M. K., Bashyal, B. P., Gunatilaka, M. K., Arnold, A. E., and Gunatilaka, A. A. L. (2010). Maximizing chemical diversity of fungal metabolites: Biogenetically related heptaketides of the endolichenic fungus Corynespora sp. (1). J. Nat. Prod. 73, 1156–1159. doi:10.1021/np900684v
Wijeratne, E. M. K., Bashyal, B. P., Liu, M. X., Rocha, D. D., Gunaherath, G. M. K. B., U’Ren, J. M., et al. (2012). Geopyxins A-E, ent-kaurane diterpenoids from endolichenic fungal strains geopyxis aff. Majalis and geopyxis sp. AZ0066: Structure-activity relationships of geopyxins and their analogues. J. Nat. Prod. 75, 361–369. doi:10.1021/np200769q
Wu, F. B., Li, T. X., Yang, M. H., and Kong, L. Y. (2015). Guanacastane-type diterpenoids from the insect-associated fungus Verticillium dahliae. J. Asian Nat. Prod. Res. 18, 117–124. doi:10.1080/10286020.2015.1061511
Yan, F., Pang, J., Peng, Y., Molina, J. R., Yang, P., and Liu, S. (2016). Elevated cellular PD1/PD-L1 expression confers acquired resistance to cisplatin in small cell lung cancer cells. PLoS ONE 11, e0162925. doi:10.1371/journal.pone.0162925
Yang, Y., Bae, W. K., Lee, J. Y., Choi, Y. J., Lee, K. H., Park, M. S., et al. (2018a). Potassium usnate, a water-soluble usnic acid salt, shows enhanced bioavailability and inhibits invasion and metastasis in colorectal cancer. Sci. Rep. 8, 16234–16311. doi:10.1038/s41598-018-34709-9
Yang, Y., Bae, W. K., Nam, S. J., Jeong, M. H., Zhou, R., Park, S. Y., et al. (2018b). Acetonic extracts of the endolichenic fungus EL002332 isolated from Endocarpon pusillum exhibits anticancer activity in human gastric cancer cells. Phytomedicine 40, 106–115. doi:10.1016/j.phymed.2018.01.006
Zhang, F. L., and Feng, T. (2022). Diterpenes specially produced by fungi: Structures, biological activities, and biosynthesis (2010–2020). J. Fungi 8, 244. doi:10.3390/JOF8030244
Zhang, H., Yang, M. H., Li, Y., Cheng, X. B., Pei, Y. H., and Kong, L. Y. (2019). Seven new guanacastane-type diterpenoids from the fungus Verticillium dahliae. Fitoterapia 133, 219–224. doi:10.1016/J.FITOTE.2019.01.009
Zhou, R., Yang, Y., Park, S. Y., Nguyen, T. T., Seo, Y. W., Lee, K. H., et al. (2017). The lichen secondary metabolite atranorin suppresses lung cancer cell motility and tumorigenesis. Sci. Rep. 7, 8136–8213. doi:10.1038/s41598-017-08225-1
Keywords: Nemania sp., benzo[a]pyrene, programmed death-ligand 1, inducible T Cell costimulator ligand, radianspenes C and D, dahliane D, immune checkpoints
Citation: Varlı M, Pham HT, Kim S-M, Taş İ, Gamage CDB, Zhou R, Pulat S, Park S-Y, Sesal NC, Hur J-S, Kang KB and Kim H (2022) An acetonic extract and secondary metabolites from the endolichenic fungus Nemania sp. EL006872 exhibit immune checkpoint inhibitory activity in lung cancer cell. Front. Pharmacol. 13:986946. doi: 10.3389/fphar.2022.986946
Received: 05 July 2022; Accepted: 08 August 2022;
Published: 08 September 2022.
Edited by:
Ruiwen Zhang, University of Houston, United StatesReviewed by:
Sanjeeva Nayaka, National Botanical Research Institute (CSIR), IndiaShivankar Agrawal, Indian Council of Medical Research, India
Srichandan Padhi, Institute of Bio-Resources and Sustainable Development (IBSD), India
Weimin Gao, Barrow Neurological Institute (BNI), United States
Copyright © 2022 Varlı, Pham, Kim, Taş, Gamage, Zhou, Pulat, Park, Sesal, Hur, Kang and Kim. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hangun Kim, hangunkim@sunchon.ac.kr